A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario
- PMID: 34887598
- PMCID: PMC8601762
A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario
Abstract
Objectives: Clozapine is considered as effective medication for treatment resistant schizophrenia. Due to its potential severe adverse effects' clozapine is underused in the clinical settings. Information's on clinical use and monitoring of clozapine is lacking in middle east. This research analysis clozapine prescription and monitoring patterns a in a university teaching hospital in Saudi Arabia.
Experimental design: A retrospective observational study was conducted in the psychiatric department of a university hospital in Saudi Arabia. Patients on treatment with clozapine for minimum one year were reviewed and assessed for clozapine mandatory and non-mandatory requirements and its correlated factors.
Observation: Majority of patients were male [(n = 36) 63%] and the average age of was 36.8 ± 12.3. TRS schizophrenia[(n = 49),85%] was the common indications. Prior to initiation of clozapine all recommended guidelines was followed for all patients (100%). In addition to the blood monitoring and vitals LFT (80.75%) and weight (87.77%) were frequently measured. Hematological work up performed routinely throughout initial 18 weeks (71.9 %) and every month (59.6%). Weight gain (29.8%) was the most documented adverse effects.
Conclusion: The current study explored experiences with clozapine prescribing practices in a university hospital KSA and suggest that clozapine prescription is completely adhered with already existing guidelines in terms of dosing and monitoring. There exist a careful balance of benefit and risk in term of adverse reaction of clozapine in the local population.
Keywords: adverse reaction; clinical settings; clozapine; lab data; monitoring; saudi arabia.
Copyright © 1964–2021 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.
Figures
Similar articles
-
A qualitative exploration of clozapine prescribing and monitoring practices in the Arabian Gulf countries.Asian J Psychiatr. 2019 Jan;39:93-97. doi: 10.1016/j.ajp.2018.12.011. Epub 2018 Dec 21. Asian J Psychiatr. 2019. PMID: 30597443
-
Successful Clozapine Treatment for Treatment-Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report.Neuropsychopharmacol Rep. 2025 Mar;45(1):e12526. doi: 10.1002/npr2.12526. Neuropsychopharmacol Rep. 2025. PMID: 39835733 Free PMC article.
-
Clozapine levels and outcomes in Serbian patients with treatment-resistant psychotic disorders previously treated without measuring clozapine levels (CLOSER).Psychiatry Res. 2024 Sep;339:116070. doi: 10.1016/j.psychres.2024.116070. Epub 2024 Jun 28. Psychiatry Res. 2024. PMID: 39029392
-
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice.Eur Neuropsychopharmacol. 2024 Jul;84:35-47. doi: 10.1016/j.euroneuro.2024.04.012. Epub 2024 Apr 23. Eur Neuropsychopharmacol. 2024. PMID: 38657339 Review.
-
Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review.Metab Brain Dis. 2025 Feb 15;40(2):128. doi: 10.1007/s11011-025-01558-1. Metab Brain Dis. 2025. PMID: 39954151 Review.
References
-
- Olagunju AT, Clark SR, Baune BT. Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis. CNS Drugs . 2018;32:1011–1023. - PubMed
-
- Xu SW, Dong M, Zhang Q, Yang SY, Chen LY, Sim K et al. Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey. Psychiatry Res . 2020;287:1–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous